PortfoliosLab logo
Organon & Co. (OGN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US68622V1061

CUSIP

68622V106

IPO Date

Jun 2, 2021

Highlights

Market Cap

$3.13B

EPS (TTM)

$3.33

PE Ratio

3.64

Total Revenue (TTM)

$4.78B

Gross Profit (TTM)

$2.76B

EBITDA (TTM)

$1.17B

Year Range

$10.45 - $22.29

Target Price

$18.67

Short %

7.83%

Short Ratio

3.75

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Organon & Co., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%NovemberDecember2025FebruaryMarchApril
-58.01%
31.30%
OGN (Organon & Co.)
Benchmark (^GSPC)

Returns By Period

Organon & Co. had a return of -16.73% year-to-date (YTD) and -29.42% in the last 12 months.


OGN

YTD

-16.73%

1M

-17.06%

6M

-26.31%

1Y

-29.42%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-6.06%

1M

-3.27%

6M

-4.87%

1Y

9.44%

5Y*

14.30%

10Y*

10.11%

*Annualized

Monthly Returns

The table below presents the monthly returns of OGN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20254.29%-2.41%-0.13%-18.07%-16.73%
202415.46%6.17%7.98%-1.01%16.20%-2.95%5.60%3.68%-14.41%-1.83%-13.99%-5.99%9.92%
20237.88%-17.86%-3.96%4.72%-20.22%7.32%5.62%1.15%-20.95%-14.80%-21.54%27.39%-45.12%
20224.79%17.90%-6.43%-7.44%18.37%-11.09%-6.01%-9.25%-17.98%11.88%0.57%7.34%-4.86%
2021-14.18%-4.13%17.79%-3.25%12.08%-19.75%4.17%-12.15%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of OGN is 18, meaning it’s performing worse than 82% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of OGN is 1818
Overall Rank
The Sharpe Ratio Rank of OGN is 1313
Sharpe Ratio Rank
The Sortino Ratio Rank of OGN is 1515
Sortino Ratio Rank
The Omega Ratio Rank of OGN is 1717
Omega Ratio Rank
The Calmar Ratio Rank of OGN is 2424
Calmar Ratio Rank
The Martin Ratio Rank of OGN is 2020
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Organon & Co. (OGN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for OGN, currently valued at -0.72, compared to the broader market-2.00-1.000.001.002.003.00
OGN: -0.72
^GSPC: 0.46
The chart of Sortino ratio for OGN, currently valued at -0.90, compared to the broader market-6.00-4.00-2.000.002.004.00
OGN: -0.90
^GSPC: 0.77
The chart of Omega ratio for OGN, currently valued at 0.89, compared to the broader market0.501.001.502.00
OGN: 0.89
^GSPC: 1.11
The chart of Calmar ratio for OGN, currently valued at -0.44, compared to the broader market0.001.002.003.004.005.00
OGN: -0.44
^GSPC: 0.47
The chart of Martin ratio for OGN, currently valued at -1.19, compared to the broader market-5.000.005.0010.0015.0020.00
OGN: -1.19
^GSPC: 1.94

The current Organon & Co. Sharpe ratio is -0.72. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Organon & Co. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
-0.72
0.46
OGN (Organon & Co.)
Benchmark (^GSPC)

Dividends

Dividend History

Organon & Co. provided a 9.18% dividend yield over the last twelve months, with an annual payout of $1.12 per share. The company has been increasing its dividends for 3 consecutive years.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%$0.00$0.20$0.40$0.60$0.80$1.00$1.202021202220232024
Dividends
Dividend Yield
PeriodTTM2024202320222021
Dividend$1.12$1.12$1.12$1.12$0.56

Dividend yield

9.18%7.51%7.77%4.01%1.84%

Monthly Dividends

The table displays the monthly dividend distributions for Organon & Co.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.28$0.00$0.00$0.28
2024$0.00$0.28$0.00$0.00$0.28$0.00$0.00$0.28$0.00$0.00$0.28$0.00$1.12
2023$0.00$0.28$0.00$0.00$0.28$0.00$0.00$0.28$0.00$0.00$0.28$0.00$1.12
2022$0.00$0.28$0.00$0.00$0.28$0.00$0.00$0.28$0.00$0.00$0.28$0.00$1.12
2021$0.28$0.00$0.00$0.28$0.00$0.56

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%25.0%
OGN: 9.2%
Organon & Co. has a dividend yield of 9.18%, which means its dividend payment is significantly above the market average.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%
OGN: 27.3%
Organon & Co. has a payout ratio of 27.25%, which is quite average when compared to the overall market. This suggests that Organon & Co. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-63.31%
-10.07%
OGN (Organon & Co.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Organon & Co.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Organon & Co. was 69.56%, occurring on Nov 16, 2023. The portfolio has not yet recovered.

The current Organon & Co. drawdown is 63.31%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-69.56%Mar 3, 2022431Nov 16, 2023
-23.11%Jun 4, 20214Jun 9, 202196Oct 25, 2021100
-22.09%Nov 2, 202127Dec 9, 202153Feb 25, 202280
-3.22%Oct 26, 20212Oct 27, 20213Nov 1, 20215
-0.64%Feb 28, 20221Feb 28, 20222Mar 2, 20223

Volatility

Volatility Chart

The current Organon & Co. volatility is 22.63%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
22.63%
14.23%
OGN (Organon & Co.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Organon & Co. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items